Search results

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

In Australia and the Southeast Asia basin, the ANSTO facility offers a wide range of unique nuclear-beam techniques for cultural heritage research.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Data analysis on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.

Billions of tonnes of iron ore tailings are generated each year from the mining industry. Converting these toxic tailings into soil-like materials which can develop and sustain plant and microbial communities is critical for mine site remediation and improved environmental outcomes.

The sap extracted from Sugar Maple trees, is used to produce maple syrup. There are many conflicting theories and an absence of experimental evidence, regarding the mechanisms involved in maple sap exudation.

International study has revealed a clustering of charged particles in the microgravity environment of space,with implications for the development of materials and better drugs that depend on the mixing of two or more charged particles.

A large international team has provided an understanding of how nanoscale interactions affect the thermal stability of a type of next generation organic solar cells.

You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).